Bui Quoc, Kumar Atul, Chen Yasheng, Hamzehloo Ali, Heitsch Laura, Slowik Agnieszka, Strbian Daniel, Lee Jin-Moo, Dhar Rajat
Department of Neurology, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8111, St. Louis, MO, USA.
Department of Emergency Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Neurocrit Care. 2024 Feb;40(1):303-313. doi: 10.1007/s12028-023-01742-0. Epub 2023 May 15.
Cerebral edema has primarily been studied using midline shift or clinical deterioration as end points, which only captures the severe and delayed manifestations of a process affecting many patients with stroke. Quantitative imaging biomarkers that measure edema severity across the entire spectrum could improve its early detection, as well as identify relevant mediators of this important stroke complication.
We applied an automated image analysis pipeline to measure the displacement of cerebrospinal fluid (ΔCSF) and the ratio of lesional versus contralateral hemispheric cerebrospinal fluid (CSF) volume (CSF ratio) in a cohort of 935 patients with hemispheric stroke with follow-up computed tomography scans taken a median of 26 h (interquartile range 24-31) after stroke onset. We determined diagnostic thresholds based on comparison to those without any visible edema. We modeled baseline clinical and radiographic variables against each edema biomarker and assessed how each biomarker was associated with stroke outcome (modified Rankin Scale at 90 days).
The displacement of CSF and CSF ratio were correlated with midline shift (r = 0.52 and - 0.74, p < 0.0001) but exhibited broader ranges. A ΔCSF of greater than 14% or a CSF ratio below 0.90 identified those with visible edema: more than half of the patients with stroke met these criteria, compared with only 14% who had midline shift at 24 h. Predictors of edema across all biomarkers included a higher National Institutes of Health Stroke Scale score, a lower Alberta Stroke Program Early CT score, and lower baseline CSF volume. A history of hypertension and diabetes (but not acute hyperglycemia) predicted greater ΔCSF but not midline shift. Both ΔCSF and a lower CSF ratio were associated with worse outcome, adjusting for age, National Institutes of Health Stroke Scale score, and Alberta Stroke Program Early CT score (odds ratio 1.7, 95% confidence interval 1.3-2.2 per 21% ΔCSF).
Cerebral edema can be measured in a majority of patients with stroke on follow-up computed tomography using volumetric biomarkers evaluating CSF shifts, including in many without visible midline shift. Edema formation is influenced by clinical and radiographic stroke severity but also by chronic vascular risk factors and contributes to worse stroke outcomes.
脑水肿主要通过中线移位或临床病情恶化作为终点指标进行研究,而这些指标仅能反映影响众多卒中患者的这一过程的严重和延迟表现。能够测量整个范围内水肿严重程度的定量成像生物标志物可改善其早期检测,并识别这一重要卒中并发症的相关介质。
我们应用了一种自动图像分析流程,来测量935例半球性卒中患者队列中的脑脊液移位(ΔCSF)以及病变侧与对侧半球脑脊液(CSF)体积之比(CSF比值),这些患者在卒中发作后中位26小时(四分位间距24 - 31小时)进行了随访计算机断层扫描。我们通过与无任何可见水肿的患者进行比较来确定诊断阈值。我们针对每个水肿生物标志物对基线临床和影像学变量进行建模,并评估每个生物标志物与卒中结局(90天时的改良Rankin量表)之间的关联。
脑脊液移位和CSF比值与中线移位相关(r = 0.52和 - 0.74,p < 0.0001),但范围更广。ΔCSF大于14%或CSF比值低于0.90可识别出有可见水肿的患者:超过一半的卒中患者符合这些标准,而24小时时有中线移位的患者仅占14%。所有生物标志物的水肿预测因素包括较高的美国国立卫生研究院卒中量表评分、较低的阿尔伯塔卒中项目早期CT评分以及较低的基线CSF体积。高血压和糖尿病病史(而非急性高血糖)可预测更大的ΔCSF,但不能预测中线移位。调整年龄、美国国立卫生研究院卒中量表评分和阿尔伯塔卒中项目早期CT评分后,ΔCSF和较低的CSF比值均与较差的结局相关(每21%的ΔCSF,比值比为1.7,95%置信区间为1.3 - 2.2)。
在大多数卒中患者的随访计算机断层扫描中,可使用评估脑脊液移位的体积生物标志物来测量脑水肿,包括许多无可见中线移位的患者。水肿形成受临床和影像学卒中严重程度影响,但也受慢性血管危险因素影响,并导致更差的卒中结局。